These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25261074)

  • 1. "Managed competition" for Ireland? The single versus multiple payer debate.
    Mikkers M; Ryan P
    BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system.
    Boonen LH; Schut FT
    Health Econ Policy Law; 2011 Apr; 6(2):219-35. PubMed ID: 21122187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a business case for quality in The Netherlands? A critical analysis of the recent reforms of the health care system.
    Custers T; Arah OA; Klazinga NS
    Health Policy; 2007 Jul; 82(2):226-39. PubMed ID: 17070956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.
    Fronstin P; Ross MN
    EBRI Issue Brief; 2009 Jun; (330):1-22. PubMed ID: 19545086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care reform: managed competition and beyond.
    Custer W
    EBRI Issue Brief; 1993 Mar; (135):1-33. PubMed ID: 10129612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National health care reform and a single-payer system: messiah or pariah?
    Norato JF
    J Health Hum Serv Adm; 1997; 19(3):341-56. PubMed ID: 10168172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition policy for health care provision in the Netherlands.
    Schut FT; Varkevisser M
    Health Policy; 2017 Feb; 121(2):126-133. PubMed ID: 27923494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low institutional trust in health insurers in Dutch health care.
    Maarse H; Jeurissen P
    Health Policy; 2019 Mar; 123(3):288-292. PubMed ID: 30635139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization.
    Keegan C; Teljeur C; Turner B; Thomas S
    Eur J Health Econ; 2016 Sep; 17(7):823-31. PubMed ID: 26359243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care reform in The Netherlands: balancing corporatism, etatism, and market mechanisms.
    Schut FT
    J Health Polit Policy Law; 1995; 20(3):615-52. PubMed ID: 8530770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managed care in four managed competition OECD health systems.
    Shmueli A; Stam P; Wasem J; Trottmann M
    Health Policy; 2015 Jul; 119(7):860-73. PubMed ID: 25776034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.
    Brouns C; Douven R; Kemp R
    Health Econ; 2021 Apr; 30(4):803-819. PubMed ID: 33502788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating Dutch: challenges and opportunities in reforming health financing in Ireland.
    Ryan P; Thomas S; Normand C
    Ir J Med Sci; 2009 Sep; 178(3):245-8. PubMed ID: 19495830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Market-oriented health care reforms and policy learning in the Netherlands.
    Helderman JK; Schut FT; van der Grinten TE; van de Ven WP
    J Health Polit Policy Law; 2005; 30(1-2):189-209. PubMed ID: 15943393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dutch healthcare reform: did it result in performance improvement of health plans? A comparison of consumer experiences over time.
    Hendriks M; Spreeuwenberg P; Rademakers J; Delnoij DM
    BMC Health Serv Res; 2009 Sep; 9():167. PubMed ID: 19761580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Econ Policy Law; 2021 Jul; 16(3):273-289. PubMed ID: 32690116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.